Omnicell, Inc. (NASDAQ:OMCL) EVP Dan S. Johnston sold 31,236 shares of the firm’s stock in a transaction that occurred on Tuesday, July 20th. The stock was sold at an average price of $151.35, for a total value of $4,727,568.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
OMCL opened at $151.28 on Thursday. The company has a quick ratio of 2.76, a current ratio of 3.09 and a debt-to-equity ratio of 0.47. The company has a 50 day simple moving average of $143.97. The firm has a market cap of $6.53 billion, a PE ratio of 79.66, a P/E/G ratio of 4.92 and a beta of 1.07. Omnicell, Inc. has a 12 month low of $65.21 and a 12 month high of $154.92.
Omnicell (NASDAQ:OMCL) last posted its quarterly earnings results on Thursday, April 29th. The company reported $0.83 EPS for the quarter, beating the consensus estimate of $0.66 by $0.17. The business had revenue of $251.84 million during the quarter, compared to analysts’ expectations of $245.35 million. Omnicell had a return on equity of 8.84% and a net margin of 3.83%. As a group, sell-side analysts expect that Omnicell, Inc. will post 2.55 EPS for the current fiscal year.
Several institutional investors and hedge funds have recently bought and sold shares of OMCL. Neuberger Berman Group LLC acquired a new stake in shares of Omnicell in the 1st quarter valued at approximately $119,344,000. Norges Bank acquired a new stake in shares of Omnicell in the 4th quarter valued at approximately $62,233,000. Victory Capital Management Inc. lifted its holdings in shares of Omnicell by 1,362.3% in the 1st quarter. Victory Capital Management Inc. now owns 453,993 shares of the company’s stock valued at $58,960,000 after buying an additional 422,947 shares during the period. Oak Ridge Investments LLC raised its holdings in Omnicell by 735.7% during the first quarter. Oak Ridge Investments LLC now owns 419,589 shares of the company’s stock worth $54,492,000 after purchasing an additional 369,378 shares during the last quarter. Finally, BlackRock Inc. raised its holdings in Omnicell by 4.5% during the first quarter. BlackRock Inc. now owns 6,965,056 shares of the company’s stock worth $904,552,000 after purchasing an additional 301,987 shares during the last quarter.
Omnicell Company Profile
Omnicell, Inc engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation.
Read More: Do You Need a Fiduciary?
Receive News & Ratings for Omnicell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell and related companies with MarketBeat.com's FREE daily email newsletter.